Replies to post #36 on Amylyx Pharmaceuticals Inc (AMLX)

[girlfriend]

They failed the phase3 for the Phoenix trial and are now going to huddle to see what the next steps are. That's bad news.

I didn't expect the shares to break down as much as they have but I have been a buyer today in the 2.90's up to 3.30.

Best of luck to all they have a rather clean balance sheet.

[DD14]

262 employees and 400 million in revenue in 2023, that’s why I’m taking advantage on this one drug refusal : )))) they have 5 million in cash and revenues.